Do you have pancreatic ductal adenocarcinoma that has come back after receiving standard therapy? If so, you may be able to participate in this gene therapy research study to learn more about using you own modified immune cells as possible treatment.

This study will evaluate the feasibility of using capillary blood samples collected with the Tasso device for analysis of CBC in diseased patients with leukemia, lymphoma, and/or other blood cell disorders.

Have you been diagnosed with a B cell disease that has returned after your previous treatment or is not responding to your current treatment? If so, you might be able to take part in a study to see if a new treatment is safe and can help treat people with B-cell diseases.

Have you been diagnosed with multiple myeloma? Have you been prescribed daratumumab for the first time? You may be able to take part in a research study to help us learn more about severe and fatal infusion-related reactions in patients with multiple myeloma.

You will be informed of the purpose of this study at the end of the survey.

The purpose of this study is to identify why households waste food. Using these causes of household food waste, we will work with participants to develop a comprehensive packet of tools that can be implemented in their daily lives to prevent food waste.

Have you ever wondered what environmental toxins you are exposed to on a daily basis, and how it might affect your health? The STRIVE study is looking for volunteers who would like to provide blood, urine, and/or saliva, as well as home samples such as soil, dust, and/or water. In this study, we want to learn more about the environmental factors that contribute to advanced liver disease and liver cancer. We are looking for healthy volunteers and people with liver cirrhosis who live in either North Carolina or Georgia to take part.

Do you have Non-Small Cell Lung Cancer? Have you previously been treated with Osimertinib? If so, you may be eligible for a trial comparing osimertinib in combination with other medications to treat your lung cancer. Please reach out if you're interested!

Have you been diagnosed with early stage triple negative breast cancer? We are asking you to take part in this research study because you have been diagnosed with triple-negative breast cancer (TNBC) and have recently completed preoperative chemotherapy in combination with pembrolizumab, followed by breast surgery. The chemotherapy plus pembrolizumab produced a pathologic complete response (pCR), meaning that no remaining cancer was found during your breast surgery.

In this project, we want to learn more about transgender and nonbinary individuals' sexual satisfaction. Sexual satisfaction is a prominent indicator of an individual's well-being and satisfaction with life. Current research focuses mainly on cisgender heterosexual populations. By focusing on people who identify under the nonbinary umbrella, in addition to binary-identifying trans people, we hope to examine how gender, the sociopolitical world, and a person's sexual satisfaction all intersect.